196 related articles for article (PubMed ID: 27477778)
41. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
42. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.
Linn YC; Hui KM
Leuk Lymphoma; 2003 Sep; 44(9):1457-62. PubMed ID: 14565644
[TBL] [Abstract][Full Text] [Related]
43. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.
Ogasawara K; Yoshinaga SK; Lanier LL
J Immunol; 2002 Oct; 169(7):3676-85. PubMed ID: 12244160
[TBL] [Abstract][Full Text] [Related]
44. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
45. Ex vivo activation of CD56(+) immune cells that eradicate neuroblastoma.
Rujkijyanont P; Chan WK; Eldridge PW; Lockey T; Holladay M; Rooney B; Davidoff AM; Leung W; Vong Q
Cancer Res; 2013 Apr; 73(8):2608-18. PubMed ID: 23440424
[TBL] [Abstract][Full Text] [Related]
46. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
47. Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.
Zhao L; Gao X; Peng Y; Joyee AG; Bai H; Wang S; Yang J; Zhao W; Yang X
Immunology; 2011 Oct; 134(2):172-84. PubMed ID: 21896012
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells.
Sarkar S; Germeraad WT; Rouschop KM; Steeghs EM; van Gelder M; Bos GM; Wieten L
PLoS One; 2013; 8(5):e64835. PubMed ID: 23724099
[TBL] [Abstract][Full Text] [Related]
49. Human peripheral blood DNAM-1
Stannard KA; Lemoine S; Waterhouse NJ; Vari F; Chatenoud L; Gandhi MK; Martinet L; Smyth MJ; Guillerey C
Blood Adv; 2019 Jun; 3(11):1681-1694. PubMed ID: 31167820
[TBL] [Abstract][Full Text] [Related]
50. Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy.
Zamai L; Del Zotto G; Buccella F; Gabrielli S; Canonico B; Artico M; Ortolani C; Papa S
Cells; 2020 Mar; 9(3):. PubMed ID: 32204481
[TBL] [Abstract][Full Text] [Related]
51. Differential effects of ifosfamide on dendritic cell-mediated stimulation of T cell interleukin-2 production, natural killer cell cytotoxicity and interferon-gamma production.
Kuppner MC; Bleifuss E; Noessner E; Mocikat R; Hesler Cv; Mayerhofer C; Issels RD
Clin Exp Immunol; 2008 Sep; 153(3):429-38. PubMed ID: 18647323
[TBL] [Abstract][Full Text] [Related]
52. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.
Snapper SB; Rosen FS; Mizoguchi E; Cohen P; Khan W; Liu CH; Hagemann TL; Kwan SP; Ferrini R; Davidson L; Bhan AK; Alt FW
Immunity; 1998 Jul; 9(1):81-91. PubMed ID: 9697838
[TBL] [Abstract][Full Text] [Related]
53. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
54. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
55. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.
Condiotti R; Zakai YB; Barak V; Nagler A
Exp Hematol; 2001 Jan; 29(1):104-13. PubMed ID: 11164111
[TBL] [Abstract][Full Text] [Related]
56. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12.
Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C
Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347
[TBL] [Abstract][Full Text] [Related]
57. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
58. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.
Prajeeth CK; Haeberlein S; Sebald H; Schleicher U; Bogdan C
Infect Immun; 2011 Jul; 79(7):2699-708. PubMed ID: 21518784
[TBL] [Abstract][Full Text] [Related]
59. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
60. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
